H. Wedemeyer Et Al. , "PROLONGED THERAPY OF HEPATITIS DELTA FOR 96 WEEKS WITH PEGYLATED-INTERFERON-alpha-2a PLUS TENOFOVIR OR PLACEBO DOES NOT PREVENT HDV RNA RELAPSE AFTER TREATMENT: THE HIDIT-2 STUDY," 49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver , vol.60, London, Canada, 2014
Wedemeyer, H. Et Al. 2014. PROLONGED THERAPY OF HEPATITIS DELTA FOR 96 WEEKS WITH PEGYLATED-INTERFERON-alpha-2a PLUS TENOFOVIR OR PLACEBO DOES NOT PREVENT HDV RNA RELAPSE AFTER TREATMENT: THE HIDIT-2 STUDY. 49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver , (London, Canada).
Wedemeyer, H., Yurdaydin, C., Ernst, S., Caruntu, F. A., Curescu, M. G., Yalcin, K., ... Akarca, U. S.(2014). PROLONGED THERAPY OF HEPATITIS DELTA FOR 96 WEEKS WITH PEGYLATED-INTERFERON-alpha-2a PLUS TENOFOVIR OR PLACEBO DOES NOT PREVENT HDV RNA RELAPSE AFTER TREATMENT: THE HIDIT-2 STUDY . 49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver, London, Canada
Wedemeyer, H. Et Al. "PROLONGED THERAPY OF HEPATITIS DELTA FOR 96 WEEKS WITH PEGYLATED-INTERFERON-alpha-2a PLUS TENOFOVIR OR PLACEBO DOES NOT PREVENT HDV RNA RELAPSE AFTER TREATMENT: THE HIDIT-2 STUDY," 49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver, London, Canada, 2014
Wedemeyer, H. Et Al. "PROLONGED THERAPY OF HEPATITIS DELTA FOR 96 WEEKS WITH PEGYLATED-INTERFERON-alpha-2a PLUS TENOFOVIR OR PLACEBO DOES NOT PREVENT HDV RNA RELAPSE AFTER TREATMENT: THE HIDIT-2 STUDY." 49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver , London, Canada, 2014
Wedemeyer, H. Et Al. (2014) . "PROLONGED THERAPY OF HEPATITIS DELTA FOR 96 WEEKS WITH PEGYLATED-INTERFERON-alpha-2a PLUS TENOFOVIR OR PLACEBO DOES NOT PREVENT HDV RNA RELAPSE AFTER TREATMENT: THE HIDIT-2 STUDY." 49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver , London, Canada.
@conferencepaper{conferencepaper, author={H. Wedemeyer Et Al. }, title={PROLONGED THERAPY OF HEPATITIS DELTA FOR 96 WEEKS WITH PEGYLATED-INTERFERON-alpha-2a PLUS TENOFOVIR OR PLACEBO DOES NOT PREVENT HDV RNA RELAPSE AFTER TREATMENT: THE HIDIT-2 STUDY}, congress name={49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver}, city={London}, country={Canada}, year={2014}}